Cited by

• CDK4/6 Inhibitors in Breast Cancer Treatment: Potential Interactions with Drug, Gene, and Pathophysiological Conditions.

  Roncato R, Angelini J, Pani A, Cecchin E, Sartore-Bianchi A, Siena S, De Mattia E, Scaglione F, Toffoli G. Roncato R, et al. Int J Mol Sci. 2020 Sep 1;21(17):6350. doi: 10.3390/ijms21176350. Int J Mol Sci. 2020. PMID: 32883002 Free PMC article. Review.
• Role of the lean body mass and of pharmacogenetic variants on the pharmacokinetics and pharmacodynamics of sunitinib in cancer patients.

  Narjoz C, Cessot A, Thomas-Schoemann A, Golmard JL, Huillard O, Boudou-Rouquette P, Behouche A, Taieb F, Durand JP, Dauphin A, Coriat R, Vidal M, Tod M, Alexandre J, Loriot MA, Goldwasser F, Blanchet B. Narjoz C, et al. Invest New Drugs. 2015 Feb;33(1):257-68. doi: 10.1007/s10637-014-0178-2. Epub 2014 Oct 25. Invest New Drugs. 2015. PMID: 25344452 Clinical Trial.
• Safety of pazopanib and sunitinib in treatment-naive patients with metastatic renal cell carcinoma: Asian versus non-Asian subgroup analysis of the COMPARZ trial.

  Guo J, Jin J, Oya M, Uemura H, Takahashi S, Tatsugami K, Rha SY, Lee JL, Chung J, Lim HY, Wu HC, Chang YH, Azad A, Davis ID, Carrasco-Alfonso MJ, Nanua B, Han J, Ahmad Q, Motzer R. Guo J, et al. J Hematol Oncol. 2018 May 22;11(1):69. doi: 10.1186/s13045-018-0617-1. J Hematol Oncol. 2018. PMID: 29788981 Free PMC article. Clinical Trial.
• Pharmacokinetic/Pharmacodynamic Analysis of a Hemodialyzed Patient Treated with 25 mg of Sunitinib.

  Noda S, Kageyama S, Tsuru T, Kubota S, Yoshida T, Okamoto K, Okada Y, Morita SY, Terada T. Noda S, et al. Case Rep Oncol. 2012 Sep;5(3):627-32. doi: 10.1159/000345694. Epub 2012 Sep 21. Case Rep Oncol. 2012. PMID: 23275777 Free PMC article.
• Identification of Febuxostat as a New Strong ABCG2 Inhibitor: Potential Applications and Risks in Clinical Situations.

  Miyata H, Takada T, Toyoda Y, Matsuo H, Ichida K, Suzuki H. Miyata H, et al. Front Pharmacol. 2016 Dec 27;7:518. doi: 10.3389/fphar.2016.00518. eCollection 2016. Front Pharmacol. 2016. PMID: 28082903 Free PMC article.